Robert O’Neil has served as a director since the completion of the IPO. Mr. O’Neil has served as a healthcare industry advisor to Avista since April 2015.
Most recently, he was Worldwide Vice President of Business Development for Johnson & Johnson’s Consumer Group of Companies from November 2002 to May 2014 and concurrently served as a Member of the Consumer Group Operating Committee and a member of the board for the Johnson & Johnson Development Corp. Previously, he was Vice President, Business Development, for Johnson & Johnson’s Pharmaceutical Group from 1994 to November 2002. From 1991 to 1993, Mr. O’Neil was Senior Vice President, Sales, Marketing, New Product Development, for Ortho McNeil Pharmaceutical (a wholly-owned company of Johnson & Johnson). He was also a member of the board of directors of Ortho McNeil Pharmaceutical Management. Prior to that role, Mr. O’Neil held various leadership positions in sales and marketing with Johnson & Johnson beginning in 1974. Mr. O’Neil currently serves as Chairman of the Board of Kramer Laboratories and as a Director of OptiNose (NASDAQ: OPTN) and Trimb Healthcare AB.
Mr. O’Neil received a B.S. from the Stillman School of Business at Seton Hall University and a M.B.A. from the Tobin College of Business at St. John’s University. Mr. O’Neil was chosen as a director due to his extensive experience in the pharmaceutical and healthcare industries.